US FDA changes informed consent requirements
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration is amending its regulations to ensure that informed consent documents and processes for certain drugs, biologics and device trials are changed to notify potential subjects that information about the concerned trial has been, or will be, included in a publicly accessible database (www.ClinicalTrials.gov)1.
You may also be interested in...
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.